Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
larger decrease » marked decrease (Expand Search)
age increased » rate increased (Expand Search), use increased (Expand Search), cases increased (Expand Search)
Showing 181 - 200 results of 29,129 for search '(( significant ((larger decrease) OR (age increased)) ) OR ( significant decrease decrease ))', query time: 0.54s Refine Results
  1. 181
    Age-standardized rates of PUD globally and for 21 GBD regions by SDI, 1990–2021.

    Age-standardized rates of PUD globally and for 21 GBD regions by SDI, 1990–2021. by Wende Hao (10315597)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 182
    Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes

    Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes by Shakkira Erimban (6882539)

    Published 2025
    Save to List
    Saved in:
  3. 183
    Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes

    Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes by Shakkira Erimban (6882539)

    Published 2025
    Save to List
    Saved in:
  4. 184
    <i>shk-1</i> mutants display decreased glycogen storage.

    <i>shk-1</i> mutants display decreased glycogen storage. by Longjun Pu (20685717)

    Published 2025
    Save to List
    Saved in:
  5. 185
    TSLPR deficient mice show decreased AHR upon HDM exposure.

    TSLPR deficient mice show decreased AHR upon HDM exposure. by Latifa Koussih (326043)

    Published 2025
    Save to List
    Saved in:
  6. 186
    HPD 1466 decreases empty capsid accumulation in cells replicating HBV.

    HPD 1466 decreases empty capsid accumulation in cells replicating HBV. by Daniel P. Bradley (10306893)

    Published 2025
    Save to List
    Saved in:
  7. 187
    RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release.

    RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

    Published 2024
    Save to List
    Saved in:
  8. 188
    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset includes variables such as demographic characteristics, clinical indicators, and measured inflammatory markers.

    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset... by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 189
    Characteristics of patients who decreased their screen time by more than 60 minutes after the challenge.

    Characteristics of patients who decreased their screen time by more than 60 minutes after the challenge. by Annaëlle Le Steunf (19838110)

    Published 2024
    Save to List
    Saved in:
  10. 190
    Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation.

    Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

    Published 2025
    Save to List
    Saved in:
  11. 191
    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n = 269.151prescriptions).

    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 192
    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.

    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 193
    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).

    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 194
    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.814 prescriptions; urologists n = 182.100 prescriptions).

    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 195
    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.

    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 196
    UTI diagnoses by sex and physician specialty (2013–2019).

    UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 197
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 198
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 199
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 200
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: